Skip to main content

Table 1 Demographics, drugs, and diagnoses by sex and by drug

From: Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)

 

Sex

Drug

 

Males

(n = 36)

Females (n = 43)

CBZ

(n = 26)

OXC

(n = 49)

Changing drug

(n = 4)

Age years (mean)

64.2

62.3

61.7

64.2

60.5

(range)

(40 to 89)

(29 to 92)

(35 to 82)

(29 to 92)

(47 to 67)

Weight kg (mean)

79.5

67.3

71.9

73.6

68.3

(95 % CI)

(75.5-83.5)

(63.7-70.9)

(67.5-76.3)

(69.4-77.8)

(60.4-76.1)

Diagnosis (%)

     

TN

91.7

97.7

96.2

93.9

100.0

SUNA

8.3

2.3

3.9

6.1

0.0

Drug (%)

     

CBZ

33.3

32.6

-

-

-

OXC

63.9

60.5

-

-

-

Changing drug

2.8

7.0

-

-

-

Males

-

-

46.2

46.9

25.0

Females

-

-

53.8

53.1

75.0